Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FHF complex subunit HOOK-interacting protein 1B (FHIP1B) is a protein component of the FTS/Hook/FHIP (FHF) complex, which promotes vesicle trafficking and/or vesicle fusion through interactions with the HOPS (homotypic fusion and protein sorting) complex[1][6]. FHIP1B functions as a cytoplasmic cargo adaptor, specifically linking the dynein motor complex to early endosomes via direct binding to Rab5B[2]. In cells, FHIP1B associates with other adaptor proteins Hook1 and Hook3 to facilitate targeting and motility of early endosomes along microtubules, contributing to endosomal organization and trafficking[2]. There is no current evidence or consensus that FHIP1B is a direct therapeutic target, nor are there any drugs known to interact with it. Disease associations are rare and largely genetic, without direct evidence for therapeutic modulation[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FHF complex subunit HOOK-interacting protein 1B (FHIP1B).